Rheumatoid Arthritis

Cushingoid appearance is a side effect of glucocorticoid use, but to date, there has been little knowledge about how glucocorticoids can change fat mass and redistribution.

The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple's ResearchKit platform, GSK's PARADE app seeks to study rheumatoid arthritis patients in their daily lives.

With the hope of wasting less time on medications doomed to fail, researchers are seeking biomarkers to predict a patient’s response to particular RA treatments.

In this article, we ask the experts to share their thoughts on the roots of doctor-patient communication challenges. Overwhelmed patients, busy doctors and technological communication rose to the top.

Biologics only slightly reduce fatigue in rheumatoid arthritis (RA) patients, a systematic review suggests.

An unorthodox treatment for rheumatoid arthritis is gaining steam in the laboratory.

EULAR 2016: Patient education and compliance often take a back seat to disease management, but they need to be at the forefront of care.

In this Q&A, Dr. Eric Ruderman of Northwestern University Feinberg School of Medicine, addresses the issue of subpar vaccination rates.

When patients can't tolerate methotrexate, it puts doctors in a conundrum, says Dr. Jeffrey Curtis of the University of Alabama in this Q&A.

Rheumatoid arthritis patients seem to embrace combination therapy over triple therapy, a new study shows.

It was "like a truck had run over me," says Andrew Lumpe, Ph.D., a patient who shares his experience with methotrexate for rheumatoid arthritis.

It’s been reiterated time and time again but the evidence holds true – smoking leads to worse health outcomes. However, smoking increases the risk of death in patients with rheumatoid arthritis.

The symptoms and pathology of rheumatoid arthritis (RA) worsened in mice models, which were missing the enzyme needed for serotonin synthesis, according to findings published in The American Journal of Pathology.

During sleep, when patients appear most still, their inflammatory systems are most active. Rheumatology Network interviews Maurizio Cutolo, M.D., who recommends prednisone at night.

The choice of a biologic agent for treating rheumatoid arthritis (RA) may influence a patient’s risk of serious infections.

Synovectomy could lead to more complications in RA patients after total knee arthroplasty, shows a study presented at the 2016 American Academy of Orthopaedic Surgeons annual meeting in Orlando this week.

For rheumatology patients, opioids have more immediate risks than addiction, says the University of Michigan's Daniel Clauw, M.D., in an interview with Rheumatology Network.

In early rheumatoid arthritis, disease activity and pain do not necessarily occur in parallel.

A head-to-head test of seven biologic agents finds that all are similarly effective in treating rheumatoid arthritis.

Hormone-related metabolic pathways in early rheumatoid arthritis may be at play, study shows.

Anakinra shown to significantly reduce pericarditis in patients with highly inflammatory disease and elevated CRP protein.

Can a person’s overall diet affect the development of rheumatoid arthritis? A new study shows that it can, especially for high-risk people.

Researchers have found several urinary biomarkers that may be used to predict rheumatoid arthritis activity and prognosis.

A new study finds promise in the combination of toclizumab and methotrexate as a treatment for early rheumatoid arthritis.

Rheumatology Network examines common comorbidities in rheumatoid arthritis and their role in limiting mobility.